{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:28:29Z","timestamp":1762918109496,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.tracli.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:30:14Z","timestamp":1589581814000},"page":"168-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of convalescent plasma in COVID-19 patients in China"],"prefix":"10.1016","volume":"27","author":[{"given":"M.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Coronavirus disease 2019 (COVID-19) Situation Report\u201399","author":"World Health Organization","key":"10.1016\/j.tracli.2020.05.001_bib0030"},{"year":"2020","series-title":"Diagnosis and treatment of novel coronavirus pneumonia (7th ed)","author":"National Health Commission of the People's Republic of China","key":"10.1016\/j.tracli.2020.05.001_bib0035"},{"key":"10.1016\/j.tracli.2020.05.001_bib0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tracli.2020.05.001_bib0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/infdis\/jiy199","article-title":"Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with ebola virus disease","volume":"218","author":"Brown","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tracli.2020.05.001_bib0050","unstructured":"Schwartz-Tapia A. Madrid Declaration on Ozone Therapy. 2th ed. Madrid: ISCO3; ISBN 978-84-606-8312-4; 2015.50p."}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782020300707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782020300707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:39Z","timestamp":1761129519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782020300707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1246782020300707"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2020.05.001","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of convalescent plasma in COVID-19 patients in China","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS).","name":"copyright","label":"Copyright"}]}}